Epidarex is pleased to announce the addition of Ryme Medical to our portfolio of medtech investments. Ryme is developing a unique catheter-based therapy that seeks to reduce symptoms and improve long-term outcomes in patients suffering with COPD.
COPD impacts more than 320 million patients worldwide. As part of this Series A round of financing, Terri Burke, Venture Partner, will join the board of directors. We are so pleased to be working with our partners at Seroba Life Sciences and Santé.
